Biodelivery Sciences International Inc
BDSIDelisted Mar 22, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001103021
Biodelivery Sciences International Inc was delisted on Mar 22, 2022; its insiders filed their last Form 4 on Mar 22, 2022; 156 institutions reported holding it in 13F filings for Q4 2021, worth $181.5M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Biodelivery Sciences International Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Biodelivery Sciences International Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Broadfin Healthcare Master Fund Ltd | Director | 0Indirect | Mar 22, 2022 | 0 |
| Broadfin Capital, LLC | Director | 0Indirect | Mar 22, 2022 | 0 |
| Kotler Kevin | Director | 0Indirect | Mar 22, 2022 | 0 |
| Sirgo Mark A | Director | 0 | Mar 22, 2022 | 0 |
| Greenleaf Peter | Director | 0 | Mar 22, 2022 | 0 |
| Davis Todd C | Director | 0 | Mar 22, 2022 | 0 |
| Bailey Jeffrey Allen | Chief Executive Officer | 0 | Mar 22, 2022 | 0 |
| Golubieski John | See Remarks | – | Mar 22, 2022 | 0 |
| Watson W. Mark | Director | 0 | Mar 22, 2022 | 0 |
| Plesha Scott M. | See Remarks | 0 | Mar 22, 2022 | 0 |
| Smith Thomas B | Chief Medical Officer | 0 | Mar 22, 2022 | 0 |
| Vollins James | See Remarks | 0 | Mar 22, 2022 | 0 |
| Singh Vanila | Director | 0 | Mar 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2022 (view filing) | Feb 4 | 4 days | Vollins JamesSee Remarks | SSale | −18.5K | $3.60 | −$66.7K | −65.3%9.87K after | |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Sirgo Mark ADirector | PPurchase | +18.6K | $2.69 | +$50.0K | +1.6%1.16M after | |
| Nov 22, 2021 (view filing)7:37 AM ET | Nov 19 | 3 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +100.0K | $3.06 | +$306.0K | +2.0%5.16M after | |
| Nov 19, 2021 (view filing) | Nov 18 | 1 day | Sirgo Mark ADirector | PPurchase | +10.0K | $3.04 | +$30.4K | +0.9%1.14M after | Amended |
| Nov 15, 2021 (view filing)7:56 AM ET | Nov 12 | 3 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +100.0K | $3.20 | +$320.0K | +2.0%5.06M after | |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Sirgo Mark ADirector | PPurchase | +16.0K | $3.20 | +$51.2K | +1.4%1.13M after | |
| Nov 9, 2021 (view filing)10:28 AM ET | Nov 5 | 4 days | Broadfin Healthcare Master Fund Ltd and 2 othersDirector | PPurchase | +257.8K | $3.47 | +$894.6K | +5.5%4.96M after |